Aclaris Therapeutics, Inc. - 8-K Filing
Aclaris Therapeutics enters underwriting agreement to issue 7.78 million shares and 6.5 million pre-funded warrants for approximately $46.7 million in net proceeds. (Items: 1.01 Entry into a Material Definitive Agreement, 9.01 Financial Statements and Exhibits)
Tickers: $ACRS